CDC is conducting seroprevalence surveys called “large-scale geographic seroprevalence surveys†in locations across the United States. The first seroprevalence surveys began in areas that first reported community transmission of SARS-CoV-2 in the United States; they are now being expanded to more regions. Descriptions of these surveys are provided on this page.… read more »